Agneta Nordberg, MD PhD - Publications

Affiliations: 
Neurobiology, Care Sciences and Society Karolinska Institute, Stockholm, Sweden 
Area:
http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=86
Website:
http://ki.se/ki/jsp/polopoly.jsp?d=34701&a=101537&l=en

265 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Murugan NA, Chiotis K, Rodriguez-Vieitez E, Lemoine L, Ågren H, Nordberg A. Cross-interaction of tau PET tracers with monoamine oxidase B: evidence from in silico modelling and in vivo imaging. European Journal of Nuclear Medicine and Molecular Imaging. PMID 30919054 DOI: 10.1007/s00259-019-04305-8  0.76
2019 Leuzy A, Savitcheva I, Chiotis K, Lilja J, Andersen P, Bogdanovic N, Jelic V, Nordberg A. Clinical impact of [F]flutemetamol PET among memory clinic patients with an unclear diagnosis. European Journal of Nuclear Medicine and Molecular Imaging. PMID 30915522 DOI: 10.1007/s00259-019-04297-5  0.76
2019 Jonasson M, Wall A, Chiotis K, Leuzy A, Eriksson J, Antoni G, Nordberg A, Lubberink M. Optimal timing of tau pathology imaging and automatic extraction of a reference region using dynamic [F]THK5317 PET. Neuroimage. Clinical. 22: 101681. PMID 30710871 DOI: 10.1016/j.nicl.2019.101681  0.76
2019 Zou R, Kuang G, Agren H, Nordberg A, Långström B, Tu Y. Free Energy Profile for Penetration of Pittsburgh Compound-B into the Amyloid β Fibril. Acs Chemical Neuroscience. PMID 30698013 DOI: 10.1021/acschemneuro.8b00662  0.6
2019 Leuzy A, Chiotis K, Lemoine L, Gillberg PG, Almkvist O, Rodriguez-Vieitez E, Nordberg A. Tau PET imaging in neurodegenerative tauopathies-still a challenge. Molecular Psychiatry. PMID 30635637 DOI: 10.1038/s41380-018-0342-8  0.76
2019 Carter SF, Herholz K, Rosa-Neto P, Pellerin L, Nordberg A, Zimmer ER. Astrocyte Biomarkers in Alzheimer's Disease. Trends in Molecular Medicine. PMID 30611668 DOI: 10.1016/j.molmed.2018.11.006  0.76
2019 Leuzy A, Cicognola C, Chiotis K, Saint-Aubert L, Lemoine L, Andreasen N, Zetterberg H, Ye K, Blennow K, Höglund K, Nordberg A. Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging. PMID 30610252 DOI: 10.1007/s00259-018-4242-6  0.76
2019 Carter SF, Chiotis K, Nordberg A, Rodriguez-Vieitez E. Longitudinal association between astrocyte function and glucose metabolism in autosomal dominant Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging. 46: 348-356. PMID 30515545 DOI: 10.1007/s00259-018-4217-7  0.76
2018 Twohig D, Rodriguez-Vieitez E, Sando SB, Berge G, Lauridsen C, Møller I, Grøntvedt GR, Bråthen G, Patra K, Bu G, Benzinger TLS, Karch CM, Fagan A, Morris JC, Bateman RJ, ... Nordberg A, et al. The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer's disease. Acta Neuropathologica Communications. 6: 130. PMID 30477568 DOI: 10.1186/s40478-018-0624-z  0.76
2018 Oliveira F, Leuzy A, Castelhano J, Chiotis K, Hasselbalch SG, Rinne J, Mendonça A, Otto M, Lleó A, Santana I, Johansson J, Anderl-Straub S, Arnim C, Beer A, Blesa R, ... ... Nordberg A, et al. Data driven diagnostic classification in Alzheimer's disease based on different reference regions for normalization of PiB-PET images and correlation with CSF concentrations of Aβ species. Neuroimage. Clinical. 20: 603-610. PMID 30186764 DOI: 10.1016/j.nicl.2018.08.023  0.76
2018 Ferreira D, Shams S, Cavallin L, Viitanen M, Martola J, Granberg T, Shams M, Aspelin P, Kristoffersen-Wiberg M, Nordberg A, Wahlund LO, Westman E. The contribution of small vessel disease to subtypes of Alzheimer's disease: a study on cerebrospinal fluid and imaging biomarkers. Neurobiology of Aging. 70: 18-29. PMID 29935417 DOI: 10.1016/j.neurobiolaging.2018.05.028  0.48
2018 Lilja J, Leuzy A, Chiotis K, Savitcheva I, Sörensen J, Nordberg A. Spatial normalization of [F]flutemetamol PET images utilizing an adaptive principal components template. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 29903930 DOI: 10.2967/jnumed.118.207811  0.76
2018 Lemoine L, Leuzy A, Chiotis K, Rodriguez-Vieitez E, Nordberg A. Tau positron emission tomography imaging in tauopathies: The added hurdle of off-target binding. Alzheimer's & Dementia (Amsterdam, Netherlands). 10: 232-236. PMID 29780868 DOI: 10.1016/j.dadm.2018.01.007  0.76
2018 Chiotis K, Stenkrona P, Almkvist O, Stepanov V, Ferreira D, Arakawa R, Takano A, Westman E, Varrone A, Okamura N, Shimada H, Higuchi M, Halldin C, Nordberg A. Dual tracer tau PET imaging reveals different molecular targets for C-THK5351 and C-PBB3 in the Alzheimer brain. European Journal of Nuclear Medicine and Molecular Imaging. PMID 29752516 DOI: 10.1007/s00259-018-4012-5  0.76
2018 Thordardottir S, Rodriguez-Vieitez E, Almkvist O, Ferreira D, Saint-Aubert L, Kinhult-Ståhlbom A, Thonberg H, Schöll M, Westman E, Wall A, Eriksdotter M, Zetterberg H, Blennow K, Nordberg A, Graff C. Reduced penetrance of the PSEN1 H163Y autosomal dominant Alzheimer mutation: a 22-year follow-up study. Alzheimer's Research & Therapy. 10: 45. PMID 29747683 DOI: 10.1186/s13195-018-0374-y  0.76
2018 Murugan NA, Nordberg A, Ågren H. Different PET tau tracers bind to multiple binding sites on the tau fibril : Insight from computational modeling. Acs Chemical Neuroscience. PMID 29630333 DOI: 10.1021/acschemneuro.8b00093  0.36
2018 Mattsson N, Groot C, Jansen WJ, Landau S, Villemagne V, Engelborghs S, Mintun M, Lleo A, Molinuevo JL, Jagust W, Frisoni GB, Ivanoiu A, Chételat G, Resende de Oliveira C, Rodrigue KM, ... ... Nordberg A, et al. Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 29601787 DOI: 10.1016/j.jalz.2018.02.009  0.4
2018 Rodriguez-Vieitez E, Nordberg A. Imaging Neuroinflammation: Quantification of Astrocytosis in a Multitracer PET Approach. Methods in Molecular Biology (Clifton, N.J.). 1750: 231-251. PMID 29512077 DOI: 10.1007/978-1-4939-7704-8_16  0.76
2018 Ni R, Ji B, Ono M, Sahara N, Zhang MR, Aoki I, Nordberg A, Suhara T, Higuchi M. Comparative in-vitro and in-vivo quantifications of pathological tau deposits and their association with neurodegeneration in tauopathy mouse models. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 29419480 DOI: 10.2967/jnumed.117.201632  0.76
2017 Leuzy A, Rodriguez-Vieitez E, Saint-Aubert L, Chiotis K, Almkvist O, Savitcheva I, Jonasson M, Lubberink M, Wall A, Antoni G, Nordberg A. Longitudinal uncoupling of cerebral perfusion, glucose metabolism, and tau deposition in Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 29268078 DOI: 10.1016/j.jalz.2017.11.008  0.76
2017 Lemoine L, Gillberg PG, Svedberg M, Stepanov V, Jia Z, Huang J, Nag S, Tian H, Ghetti B, Okamura N, Higuchi M, Halldin C, Nordberg A. Comparative binding properties of the tau PET tracers THK5117, THK5351, PBB3, and T807 in postmortem Alzheimer brains. Alzheimer's Research & Therapy. 9: 96. PMID 29229003 DOI: 10.1186/s13195-017-0325-z  0.48
2017 Jansen WJ, Ossenkoppele R, Tijms BM, Fagan AM, Hansson O, Klunk WE, van der Flier WM, Villemagne VL, Frisoni GB, Fleisher AS, Lleó A, Mintun MA, Wallin A, Engelborghs S, Na DL, ... ... Nordberg A, et al. Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia. Jama Psychiatry. PMID 29188296 DOI: 10.1001/jamapsychiatry.2017.3391  0.4
2017 Balamurugan K, Murugan NA, Långström B, Nordberg A, Ågren H. Effect of Alzheimer Familial Chromosomal Mutations on the Amyloid Fibril Interaction with Different PET Tracers- Insight from Molecular Modeling Studies. Acs Chemical Neuroscience. PMID 28898051 DOI: 10.1021/acschemneuro.7b00215  0.6
2017 Frisoni GB, Boccardi M, Barkhof F, Blennow K, Cappa S, Chiotis K, Démonet JF, Garibotto V, Giannakopoulos P, Gietl A, Hansson O, Herholz K, Jack CR, Nobili F, Nordberg A, et al. Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers. The Lancet. Neurology. 16: 661-676. PMID 28721928 DOI: 10.1016/S1474-4422(17)30159-X  0.76
2017 Iaccarino L, Chiotis K, Alongi P, Almkvist O, Wall A, Cerami C, Bettinardi V, Gianolli L, Nordberg A, Perani D. A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer's Disease in a Clinical Setting. Journal of Alzheimer's Disease : Jad. 59: 603-614. PMID 28671117 DOI: 10.3233/JAD-170158  0.76
2017 Heurling K, Leuzy A, Jonasson M, Frick A, Zimmer ER, Nordberg A, Lubberink M. Quantitative positron emission tomography in brain research. Brain Research. PMID 28652218 DOI: 10.1016/j.brainres.2017.06.022  0.6
2017 Lemoine L, Saint-Aubert L, Nennesmo I, Gillberg PG, Nordberg A. Cortical laminar tau deposits and activated astrocytes in Alzheimer's disease visualised by (3)H-THK5117 and (3)H-deprenyl autoradiography. Scientific Reports. 7: 45496. PMID 28374768 DOI: 10.1038/srep45496  0.72
2017 Herukka SK, Simonsen AH, Andreasen N, Baldeiras I, Bjerke M, Blennow K, Engelborghs S, Frisoni GB, Gabryelewicz T, Galluzzi S, Handels R, Kramberger MG, Kulczyńska A, Molinuevo JL, Mroczko B, ... Nordberg A, et al. Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 13: 285-295. PMID 28341066 DOI: 10.1016/j.jalz.2016.09.009  0.44
2017 Simonsen AH, Herukka SK, Andreasen N, Baldeiras I, Bjerke M, Blennow K, Engelborghs S, Frisoni GB, Gabryelewicz T, Galluzzi S, Handels R, Kramberger MG, Kulczyńska A, Molinuevo JL, Mroczko B, ... Nordberg A, et al. Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 13: 274-284. PMID 28341065 DOI: 10.1016/j.jalz.2016.09.008  0.44
2017 Chiotis K, Saint-Aubert L, Boccardi M, Gietl A, Picco A, Varrone A, Garibotto V, Herholz K, Nobili F, Nordberg A. Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework. Neurobiology of Aging. 52: 214-227. PMID 28317650 DOI: 10.1016/j.neurobiolaging.2016.07.012  0.76
2017 Saint-Aubert L, Lemoine L, Chiotis K, Leuzy A, Rodriguez-Vieitez E, Nordberg A. Tau PET imaging: present and future directions. Molecular Neurodegeneration. 12: 19. PMID 28219440 DOI: 10.1186/s13024-017-0162-3  0.76
2017 Ono M, Sahara N, Kumata K, Ji B, Ni R, Koga S, Dickson DW, Trojanowski JQ, Lee VM, Yoshida M, Hozumi I, Yoshiyama Y, van Swieten JC, Nordberg A, Suhara T, et al. Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies. Brain : a Journal of Neurology. PMID 28087578 DOI: 10.1093/brain/aww339  0.76
2016 Stepanov V, Svedberg M, Jia Z, Krasikova R, Lemoine L, Okamura N, Furumoto S, Mitsios N, Mulder J, Långström B, Nordberg A, Halldin C. Development of [(11)C]/[(3)H]THK-5351 - A potential novel carbon-11 tau imaging PET radioligand. Nuclear Medicine and Biology. 46: 50-53. PMID 28013122 DOI: 10.1016/j.nucmedbio.2016.12.004  0.6
2016 Kuang G, Wang X, Halldin C, Nordberg A, Långström B, Ågren H, Tu Y. Theoretical study of the binding profile of an allosteric modulator NS-1738 with a chimera structure of the α7 nicotinic acetylcholine receptor. Physical Chemistry Chemical Physics : Pccp. PMID 27711412 DOI: 10.1039/c6cp02278b  0.6
2016 Ni R, Gillberg PG, Bogdanovic N, Viitanen M, Myllykangas L, Nennesmo I, Långström B, Nordberg A. Amyloid tracers binding sites in autosomal dominant and sporadic Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 27693181 DOI: 10.1016/j.jalz.2016.08.006  0.76
2016 Saint-Aubert L, Almkvist O, Chiotis K, Almeida R, Wall A, Nordberg A. Regional tau deposition measured by [(18)F]THK5317 positron emission tomography is associated to cognition via glucose metabolism in Alzheimer's disease. Alzheimer's Research & Therapy. 8: 38. PMID 27683159 DOI: 10.1186/s13195-016-0204-z  0.76
2016 Natarajan AM, Halldin C, Nordberg A, Långström B, Ågren H. The Culprit Is in the Cave: The Core Sites Explain the Binding Profiles of Amyloid Specific Tracers. The Journal of Physical Chemistry Letters. PMID 27498616 DOI: 10.1021/acs.jpclett.6b01586  0.6
2016 Minoshima S, Drzezga AE, Barthel H, Bohnen N, Djekidel M, Lewis DH, Mathis CA, McConathy J, Nordberg A, Sabri O, Seibyl JP, Stokes MK, Van Laere K. SNMMI Procedure Standard/EANM Practice Guideline for Amyloid PET Imaging of the Brain 1.0. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 57: 1316-22. PMID 27481605 DOI: 10.2967/jnumed.116.174615  0.76
2016 Leuzy A, Chiotis K, Hasselbalch SG, Rinne JO, de Mendonça A, Otto M, Lleó A, Castelo-Branco M, Santana I, Johansson J, Anderl-Straub S, von Arnim CA, Beer A, Blesa R, Fortea J, ... ... Nordberg A, et al. Pittsburgh compound B imaging and cerebrospinal fluid amyloid-β in a multicentre European memory clinic study. Brain : a Journal of Neurology. PMID 27401520 DOI: 10.1093/brain/aww160  0.76
2016 Eyjolfsdottir H, Eriksdotter M, Linderoth B, Lind G, Juliusson B, Kusk P, Almkvist O, Andreasen N, Blennow K, Ferreira D, Westman E, Nennesmo I, Karami A, Darreh-Shori T, Kadir A, ... Nordberg A, et al. Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer's disease patients: application of a second-generation encapsulated cell biodelivery device. Alzheimer's Research & Therapy. 8: 30. PMID 27389402 DOI: 10.1186/s13195-016-0195-9  0.76
2016 Rodriguez-Vieitez E, Leuzy A, Chiotis K, Saint-Aubert L, Wall A, Nordberg A. Comparability of [18F]THK5317 and [11C]PIB blood flow proxy images with [18F]FDG positron emission tomography in Alzheimer's disease. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. PMID 27107028 DOI: 10.1177/0271678X16645593  0.76
2016 Chiotis K, Saint-Aubert L, Savitcheva I, Jelic V, Andersen P, Jonasson M, Eriksson J, Lubberink M, Almkvist O, Wall A, Antoni G, Nordberg A. Imaging in-vivo tau pathology in Alzheimer's disease with THK5317 PET in a multimodal paradigm. European Journal of Nuclear Medicine and Molecular Imaging. 43: 1686-99. PMID 26996778 DOI: 10.1007/s00259-016-3363-z  0.76
2016 Winblad B, Amouyel P, Andrieu S, Ballard C, Brayne C, Brodaty H, Cedazo-Minguez A, Dubois B, Edvardsson D, Feldman H, Fratiglioni L, Frisoni GB, Gauthier S, Georges J, Graff C, ... ... Nordberg A, et al. Defeating Alzheimer's disease and other dementias: a priority for European science and society. The Lancet. Neurology. 15: 455-532. PMID 26987701 DOI: 10.1016/S1474-4422(16)00062-4  0.44
2016 Rodriguez-Vieitez E, Carter SF, Chiotis K, Saint-Aubert L, Leuzy A, Schöll M, Almkvist O, Wall A, Långström B, Nordberg A. Comparison of Early-Phase 11C-Deuterium-L-Deprenyl and 11C-PiB PET for Assessing Brain Perfusion in Alzheimer's Disease. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 26912447 DOI: 10.2967/jnumed.115.168732  0.76
2016 Rodriguez-Vieitez E, Saint-Aubert L, Carter SF, Almkvist O, Farid K, Schöll M, Chiotis K, Thordardottir S, Graff C, Wall A, Långström B, Nordberg A. Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease. Brain : a Journal of Neurology. PMID 26813969 DOI: 10.1093/brain/awv404  0.76
2016 Jonasson M, Wall A, Chiotis K, Saint-Aubert L, Wilking H, Sprycha M, Borg B, Thibblin A, Eriksson JP, Sörensen J, Antoni G, Nordberg A, Lubberink M. Tracer kinetic analysis of (S)-18F-THK5117 as a PET tracer for assessing tau pathology. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 26795290 DOI: 10.2967/jnumed.115.158519  0.76
2016 Heurling K, Leuzy A, Zimmer ER, Lubberink M, Nordberg A. Imaging β-amyloid using [(18)F]flutemetamol positron emission tomography: from dosimetry to clinical diagnosis. European Journal of Nuclear Medicine and Molecular Imaging. 43: 362-73. PMID 26440450 DOI: 10.1007/s00259-015-3208-1  0.6
2016 Heurling K, Leuzy A, Zimmer ER, Lubberink M, Nordberg A. Imaging β-amyloid using [18F]flutemetamol positron emission tomography: from dosimetry to clinical diagnosis European Journal of Nuclear Medicine and Molecular Imaging. 43: 362-373. DOI: 10.1007/s00259-015-3208-1  0.6
2015 Schöll M, Carter SF, Westman E, Rodriguez-Vieitez E, Almkvist O, Thordardottir S, Wall A, Graff C, Långström B, Nordberg A. Early astrocytosis in autosomal dominant Alzheimer's disease measured in vivo by multi-tracer positron emission tomography. Scientific Reports. 5: 16404. PMID 26553227 DOI: 10.1038/srep16404  0.76
2015 Kumar R, Nordberg A, Darreh-Shori T. Amyloid-β peptides act as allosteric modulators of cholinergic signalling through formation of soluble BAβACs. Brain : a Journal of Neurology. PMID 26525916 DOI: 10.1093/brain/awv318  0.52
2015 Zwan MD, Rinne JO, Hasselbalch SG, Nordberg A, Lleó A, Herukka SK, Soininen H, Law I, Bahl JM, Carter SF, Fortea J, Blesa R, Teunissen CE, Bouwman FH, van Berckel BN, et al. Use of amyloid-PET to determine cutpoints for CSF markers: A multicenter study. Neurology. PMID 26468410 DOI: 10.1212/WNL.0000000000002081  0.76
2015 Nordberg A, Kadir A, Andreasen N, Almkvist O, Wall A, Långström B, Zetterberg H. Correlations between Alzheimer's Disease Cerebrospinal Fluid Biomarkers and Cerebral Glucose Metabolism after 12 Months of Phenserine Treatment. Journal of Alzheimer's Disease : Jad. 47: 691-704. PMID 26401704 DOI: 10.3233/JAD-132474  0.76
2015 Farid K, Carter SF, Rodriguez-Vieitez E, Almkvist O, Andersen P, Wall A, Blennow K, Portelius E, Zetterberg H, Nordberg A. Case Report of Complex Amyotrophic Lateral Sclerosis with Cognitive Impairment and Cortical Amyloid Deposition. Journal of Alzheimer's Disease : Jad. 47: 661-7. PMID 26401701 DOI: 10.3233/JAD-141965  0.76
2015 Kuang G, Murugan NA, Tu Y, Nordberg A, Ågren H. Investigation of the Binding Profiles of AZD2184 and Thioflavin T with Amyloid-β(1-42) Fibril by Molecular Docking and Molecular Dynamics Methods. The Journal of Physical Chemistry. B. 119: 11560-7. PMID 26266837 DOI: 10.1021/acs.jpcb.5b05964  0.76
2015 Lilja AM, Malmsten L, Röjdner J, Voytenko L, Verkhratsky A, Ögren SO, Nordberg A, Marutle A. Neural Stem Cell Transplant-Induced Effect on Neurogenesis and Cognition in Alzheimer Tg2576 Mice Is Inhibited by Concomitant Treatment with Amyloid-Lowering or Cholinergic α7 Nicotinic Receptor Drugs. Neural Plasticity. 2015: 370432. PMID 26257960 DOI: 10.1155/2015/370432  0.76
2015 Lemoine L, Saint-Aubert L, Marutle A, Antoni G, Eriksson JP, Ghetti B, Okamura N, Nennesmo I, Gillberg PG, Nordberg A. Visualization of regional tau deposits using (3)H-THK5117 in Alzheimer brain tissue. Acta Neuropathologica Communications. 3: 40. PMID 26134112 DOI: 10.1186/s40478-015-0220-4  0.72
2015 Chiotis K, Carter SF, Farid K, Savitcheva I, Nordberg A. Amyloid PET in European and North American cohorts; and exploring age as a limit to clinical use of amyloid imaging. European Journal of Nuclear Medicine and Molecular Imaging. 42: 1492-506. PMID 26130168 DOI: 10.1007/s00259-015-3115-5  0.76
2015 Jansen WJ, Ossenkoppele R, Knol DL, Tijms BM, Scheltens P, Verhey FR, Visser PJ, Aalten P, Aarsland D, Alcolea D, Alexander M, Almdahl IS, Arnold SE, Baldeiras I, ... ... Nordberg A, et al. Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. Jama. 313: 1924-38. PMID 25988462 DOI: 10.1001/jama.2015.4668  0.76
2015 Rodriguez-Vieitez E, Ni R, Gulyás B, Tóth M, Häggkvist J, Halldin C, Voytenko L, Marutle A, Nordberg A. Astrocytosis precedes amyloid plaque deposition in Alzheimer APPswe transgenic mouse brain: a correlative positron emission tomography and in vitro imaging study. European Journal of Nuclear Medicine and Molecular Imaging. 42: 1119-32. PMID 25893384 DOI: 10.1007/s00259-015-3047-0  0.76
2015 Andreasen N, Simeoni M, Ostlund H, Lisjo PI, Fladby T, Loercher AE, Byrne GJ, Murray F, Scott-Stevens PT, Wallin A, Zhang YY, Bronge LH, Zetterberg H, Nordberg AK, Yeo AJ, et al. First administration of the Fc-attenuated anti-β amyloid antibody GSK933776 to patients with mild Alzheimer's disease: a randomized, placebo-controlled study. Plos One. 10: e0098153. PMID 25789616 DOI: 10.1371/journal.pone.0098153  0.4
2015 Karami A, Eyjolfsdottir H, Vijayaraghavan S, Lind G, Almqvist P, Kadir A, Linderoth B, Andreasen N, Blennow K, Wall A, Westman E, Ferreira D, Kristoffersen Wiberg M, Wahlund LO, Seiger Å, ... Nordberg A, et al. Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 25676388 DOI: 10.1016/j.jalz.2014.11.008  0.76
2015 Leuzy A, Carter SF, Chiotis K, Almkvist O, Wall A, Nordberg A. Concordance and Diagnostic Accuracy of [11C]PIB PET and Cerebrospinal Fluid Biomarkers in a Sample of Patients with Mild Cognitive Impairment and Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. 45: 1077-88. PMID 25649653 DOI: 10.3233/JAD-142952  0.76
2015 Prestia A, Caroli A, Wade SK, van der Flier WM, Ossenkoppele R, Van Berckel B, Barkhof F, Teunissen CE, Wall A, Carter SF, Schöll M, Choo IH, Nordberg A, Scheltens P, Frisoni GB. Prediction of AD dementia by biomarkers following the NIA-AA and IWG diagnostic criteria in MCI patients from three European memory clinics. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 25646957 DOI: 10.1016/j.jalz.2014.12.001  0.76
2015 Caroli A, Prestia A, Galluzzi S, Ferrari C, van der Flier WM, Ossenkoppele R, Van Berckel B, Barkhof F, Teunissen C, Wall AE, Carter SF, Schöll M, Choo IH, Grimmer T, Redolfi A, ... Nordberg A, et al. Mild cognitive impairment with suspected nonamyloid pathology (SNAP): Prediction of progression. Neurology. 84: 508-15. PMID 25568301 DOI: 10.1212/WNL.0000000000001209  0.76
2015 Varrone A, Oikonen V, Forsberg A, Joutsa J, Takano A, Solin O, Haaparanta-Solin M, Nag S, Nakao R, Al-Tawil N, Wells LA, Rabiner EA, Valencia R, Schultze-Mosgau M, Thiele A, ... ... Nordberg A, et al. Positron emission tomography imaging of the 18-kDa translocator protein (TSPO) with [18F]FEMPA in Alzheimer's disease patients and control subjects. European Journal of Nuclear Medicine and Molecular Imaging. 42: 438-46. PMID 25412766 DOI: 10.1007/s00259-014-2955-8  0.76
2015 Bocchetta M, Galluzzi S, Kehoe PG, Aguera E, Bernabei R, Bullock R, Ceccaldi M, Dartigues JF, de Mendonça A, Didic M, Eriksdotter M, Félician O, Frölich L, Gertz HJ, Hallikainen M, ... ... Nordberg A, et al. The use of biomarkers for the etiologic diagnosis of MCI in Europe: an EADC survey. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: 195-206.e1. PMID 25150733 DOI: 10.1016/j.jalz.2014.06.006  0.76
2015 Nordberg A, Kadir A, Andreasen N, Almkvist O, Wall A, Blennow K, Langstrom B, Zetterberg H. Correlations between Alzheimer's Disease Cerebrospinal Fluid Biomarkers and Cerebral Glucose Metabolism after 12 Months of Phenserine Treatment Journal of Alzheimer's Disease. 47: 691-704. DOI: 10.3233/JAD-132474  0.76
2015 Varrone A, Nordberg A. Molecular imaging of neuroinflammation in Alzheimer’s disease Clinical and Translational Imaging. 3: 437-447. DOI: 10.1007/s40336-015-0137-8  0.76
2015 Nordberg A. The use of amyloid imaging in clinical praxis: a critical review Clinical and Translational Imaging. 3: 7-11. DOI: 10.1007/s40336-015-0100-8  0.76
2015 Chiotis K, Carter SF, Farid K, Savitcheva I, Nordberg A. Amyloid PET in European and North American cohorts; and exploring age as a limit to clinical use of amyloid imaging European Journal of Nuclear Medicine and Molecular Imaging. 42: 1492-1506. DOI: 10.1007/s00259-015-3115-5  0.76
2014 Almkvist O, Kadir A, Nordberg A. Degree of abnormality is associated with rate of change in measures of beta-amyloid, glucose metabolism and cognition in an autopsy-verified Alzheimer's disease case. Neurocase. 1-10. PMID 25494540 DOI: 10.1080/13554794.2014.979835  0.76
2014 Murugan NA, Zale?ny R, Kongsted J, Nordberg A, Ågren H. Promising two-photon probes for in vivo detection of β amyloid deposits. Chemical Communications (Cambridge, England). 50: 11694-7. PMID 25141215 DOI: 10.1039/c4cc03897e  0.76
2014 Verkhratsky A, Marutle A, Rodríguez-Arellano JJ, Nordberg A. Glial Asthenia and Functional Paralysis: A New Perspective on Neurodegeneration and Alzheimer's Disease. The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry. PMID 25125026 DOI: 10.1177/1073858414547132  0.76
2014 Choo IL, Carter SF, Schöll ML, Nordberg A. Astrocytosis measured by ¹¹C-deprenyl PET correlates with decrease in gray matter density in the parahippocampus of prodromal Alzheimer's patients. European Journal of Nuclear Medicine and Molecular Imaging. 41: 2120-6. PMID 25077930 DOI: 10.1007/s00259-014-2859-7  0.76
2014 Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, DeKosky ST, Gauthier S, Selkoe D, Bateman R, Cappa S, Crutch S, Engelborghs S, Frisoni GB, Fox NC, ... ... Nordberg A, et al. Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria. The Lancet. Neurology. 13: 614-29. PMID 24849862 DOI: 10.1016/S1474-4422(14)70090-0  0.76
2014 Morris JC, Blennow K, Froelich L, Nordberg A, Soininen H, Waldemar G, Wahlund LO, Dubois B. Harmonized diagnostic criteria for Alzheimer's disease: recommendations. Journal of Internal Medicine. 275: 204-13. PMID 24605805 DOI: 10.1111/joim.12199  0.76
2014 Nordberg A. Molecular imaging in sporadic Alzheimer's disease populations and those genetically at risk. Neuro-Degenerative Diseases. 13: 160-2. PMID 24434947 DOI: 10.1159/000356333  0.76
2014 Darreh-Shori T, Hosseini SM, Nordberg A. Pharmacodynamics of cholinesterase inhibitors suggests add-on therapy with a low-dose carbamylating inhibitor in patients on long-term treatment with rapidly reversible inhibitors. Journal of Alzheimer's Disease : Jad. 39: 423-40. PMID 24217282 DOI: 10.3233/JAD-130845  0.76
2014 Nordberg A. PET tracers for beta-amyloid and other proteinopathies Pet and Spect of Neurobiological Systems. 199-212. DOI: 10.1007/978-3-642-42014-6_8  0.76
2013 Nordberg A, Ballard C, Bullock R, Darreh-Shori T, Somogyi M. A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer's disease. The Primary Care Companion For Cns Disorders. 15. PMID 23930233 DOI: 10.4088/PCC.12r01412  0.76
2013 Frisoni GB, Bocchetta M, Chételat G, Rabinovici GD, de Leon MJ, Kaye J, Reiman EM, Scheltens P, Barkhof F, Black SE, Brooks DJ, Carrillo MC, Fox NC, Herholz K, Nordberg A, et al. Imaging markers for Alzheimer disease: which vs how. Neurology. 81: 487-500. PMID 23897875 DOI: 10.1212/WNL.0b013e31829d86e8  0.76
2013 Marutle A, Gillberg PG, Bergfors A, Yu W, Ni R, Nennesmo I, Voytenko L, Nordberg A. ³H-deprenyl and ³H-PIB autoradiography show different laminar distributions of astroglia and fibrillar β-amyloid in Alzheimer brain. Journal of Neuroinflammation. 10: 90. PMID 23880036 DOI: 10.1186/1742-2094-10-90  0.76
2013 Darreh-Shori T, Vijayaraghavan S, Aeinehband S, Piehl F, Lindblom RP, Nilsson B, Ekdahl KN, LÃ¥ngström B, Almkvist O, Nordberg A. Functional variability in butyrylcholinesterase activity regulates intrathecal cytokine and astroglial biomarker profiles in patients with Alzheimer's disease. Neurobiology of Aging. 34: 2465-81. PMID 23759148 DOI: 10.1016/j.neurobiolaging.2013.04.027  0.76
2013 Ni R, Gillberg PG, Bergfors A, Marutle A, Nordberg A. Amyloid tracers detect multiple binding sites in Alzheimer's disease brain tissue. Brain : a Journal of Neurology. 136: 2217-27. PMID 23757761 DOI: 10.1093/brain/awt142  0.76
2013 Lilja AM, Röjdner J, Mustafiz T, Thomé CM, Storelli E, Gonzalez D, Unger-Lithner C, Greig NH, Nordberg A, Marutle A. Age-dependent neuroplasticity mechanisms in Alzheimer Tg2576 mice following modulation of brain amyloid-β levels. Plos One. 8: e58752. PMID 23554921 DOI: 10.1371/journal.pone.0058752  0.76
2013 Prestia A, Caroli A, van der Flier WM, Ossenkoppele R, Van Berckel B, Barkhof F, Teunissen CE, Wall AE, Carter SF, Schöll M, Choo IH, Nordberg A, Scheltens P, Frisoni GB. Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease. Neurology. 80: 1048-56. PMID 23390179 DOI: 10.1212/WNL.0b013e3182872830  0.76
2013 Lilja AM, Luo Y, Yu QS, Röjdner J, Li Y, Marini AM, Marutle A, Nordberg A, Greig NH. Neurotrophic and neuroprotective actions of (-)- and (+)-phenserine, candidate drugs for Alzheimer's disease. Plos One. 8: e54887. PMID 23382994 DOI: 10.1371/journal.pone.0054887  0.76
2013 Edison P, Carter SF, Rinne JO, Gelosa G, Herholz K, Nordberg A, Brooks DJ, Hinz R. Comparison of MRI based and PET template based approaches in the quantitative analysis of amyloid imaging with PIB-PET. Neuroimage. 70: 423-33. PMID 23261639 DOI: 10.1016/j.neuroimage.2012.12.014  0.76
2013 Choo IH, Ni R, Schöll M, Wall A, Almkvist O, Nordberg A. Combination of 18F-FDG PET and cerebrospinal fluid biomarkers as a better predictor of the progression to Alzheimer's disease in mild cognitive impairment patients. Journal of Alzheimer's Disease : Jad. 33: 929-39. PMID 23047371 DOI: 10.3233/JAD-2012-121489  0.76
2013 Ni R, Marutle A, Nordberg A. Modulation of α7 nicotinic acetylcholine receptor and fibrillar amyloid-β interactions in Alzheimer's disease brain. Journal of Alzheimer's Disease : Jad. 33: 841-51. PMID 23042213 DOI: 10.3233/JAD-2012-121447  0.76
2013 Nordberg A, Carter SF, Rinne J, Drzezga A, Brooks DJ, Vandenberghe R, Perani D, Forsberg A, LÃ¥ngström B, Scheinin N, Karrasch M, NÃ¥gren K, Grimmer T, Miederer I, Edison P, et al. A European multicentre PET study of fibrillar amyloid in Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging. 40: 104-14. PMID 22961445 DOI: 10.1007/s00259-012-2237-2  0.76
2012 Sugaya K, Youdim MB, Nordberg A, Rao KS. Neuroprotection and neuroregeneration in Alzheimer's disease. International Journal of Alzheimer's Disease. 2012: 864138. PMID 22737586 DOI: 10.1155/2012/864138  0.76
2012 Schöll M, Wall A, Thordardottir S, Ferreira D, Bogdanovic N, LÃ¥ngström B, Almkvist O, Graff C, Nordberg A. Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers. Neurology. 79: 229-36. PMID 22700814 DOI: 10.1212/WNL.0b013e31825fdf18  0.76
2012 Eriksdotter-Jönhagen M, Linderoth B, Lind G, Aladellie L, Almkvist O, Andreasen N, Blennow K, Bogdanovic N, Jelic V, Kadir A, Nordberg A, Sundström E, Wahlund LO, Wall A, Wiberg M, et al. Encapsulated cell biodelivery of nerve growth factor to the Basal forebrain in patients with Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 33: 18-28. PMID 22377499 DOI: 10.1159/000336051  0.76
2012 Villemagne VL, Klunk WE, Mathis CA, Rowe CC, Brooks DJ, Hyman BT, Ikonomovic MD, Ishii K, Jack CR, Jagust WJ, Johnson KA, Koeppe RA, Lowe VJ, Masters CL, Montine TJ, ... ... Nordberg A, et al. Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging. 39: 209-19. PMID 22218879 DOI: 10.1007/s00259-011-2045-0  0.76
2012 Carter SF, Schöll M, Almkvist O, Wall A, Engler H, LÃ¥ngström B, Nordberg A. Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 37-46. PMID 22213821 DOI: 10.2967/jnumed.110.087031  0.76
2012 Forsberg A, Engler H, Blomquist G, LÃ¥ngström B, Nordberg A. The use of PIB-PET as a dual pathological and functional biomarker in AD. Biochimica Et Biophysica Acta. 1822: 380-5. PMID 22115832 DOI: 10.1016/j.bbadis.2011.11.006  0.76
2012 Darreh-Shori T, Siawesh M, Mousavi M, Andreasen N, Nordberg A. Apolipoprotein ε4 modulates phenotype of butyrylcholinesterase in CSF of patients with Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 28: 443-58. PMID 22012848 DOI: 10.3233/JAD-2011-111088  0.76
2012 Bao F, Wicklund L, Lacor PN, Klein WL, Nordberg A, Marutle A. Different β-amyloid oligomer assemblies in Alzheimer brains correlate with age of disease onset and impaired cholinergic activity. Neurobiology of Aging. 33: 825.e1-13. PMID 21683475 DOI: 10.1016/j.neurobiolaging.2011.05.003  0.76
2012 Kadir A, Almkvist O, Forsberg A, Wall A, Engler H, LÃ¥ngström B, Nordberg A. Dynamic changes in PET amyloid and FDG imaging at different stages of Alzheimer's disease. Neurobiology of Aging. 33: 198.e1-14. PMID 20688420 DOI: 10.1016/j.neurobiolaging.2010.06.015  0.76
2011 Nordberg A. Molecular imaging in Alzheimer's disease: new perspectives on biomarkers for early diagnosis and drug development. Alzheimer's Research & Therapy. 3: 34. PMID 22136152 DOI: 10.1186/alzrt96  0.76
2011 Lithner CU, Hedberg MM, Nordberg A. Transgenic mice as a model for Alzheimer's disease. Current Alzheimer Research. 8: 818-31. PMID 21592052 DOI: 10.2174/156720511798192736  0.76
2011 Mustafiz T, Portelius E, Gustavsson MK, Hölttä M, Zetterberg H, Blennow K, Nordberg A, Lithner CU. Characterization of the brain β-amyloid isoform pattern at different ages of Tg2576 mice. Neuro-Degenerative Diseases. 8: 352-63. PMID 21346320 DOI: 10.1159/000323871  0.76
2011 Shafaati M, Marutle A, Pettersson H, Lövgren-Sandblom A, Olin M, Pikuleva I, Winblad B, Nordberg A, Björkhem I. Marked accumulation of 27-hydroxycholesterol in the brains of Alzheimer's patients with the Swedish APP 670/671 mutation. Journal of Lipid Research. 52: 1004-10. PMID 21335619 DOI: 10.1194/jlr.M014548  0.76
2011 Schöll M, Almkvist O, Bogdanovic N, Wall A, LÃ¥ngström B, Viitanen M, Nordberg A. Time course of glucose metabolism in relation to cognitive performance and postmortem neuropathology in Met146Val PSEN1 mutation carriers. Journal of Alzheimer's Disease : Jad. 24: 495-506. PMID 21297272 DOI: 10.3233/JAD-2011-101563  0.76
2011 Keller C, Kadir A, Forsberg A, Porras O, Nordberg A. Long-term effects of galantamine treatment on brain functional activities as measured by PET in Alzheimer's disease patients. Journal of Alzheimer's Disease : Jad. 24: 109-23. PMID 21157026 DOI: 10.3233/JAD-2010-101290  0.76
2011 Kadir A, Marutle A, Gonzalez D, Schöll M, Almkvist O, Mousavi M, Mustafiz T, Darreh-Shori T, Nennesmo I, Nordberg A. Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease. Brain : a Journal of Neurology. 134: 301-17. PMID 21149866 DOI: 10.1093/brain/awq349  0.76
2011 Hampel H, Wilcock G, Andrieu S, Aisen P, Blennow K, Broich K, Carrillo M, Fox NC, Frisoni GB, Isaac M, Lovestone S, Nordberg A, Prvulovic D, Sampaio C, Scheltens P, et al. Biomarkers for Alzheimer's disease therapeutic trials. Progress in Neurobiology. 95: 579-93. PMID 21130138 DOI: 10.1016/j.pneurobio.2010.11.005  0.76
2011 Lilja AM, Porras O, Storelli E, Nordberg A, Marutle A. Functional interactions of fibrillar and oligomeric amyloid-β with alpha7 nicotinic receptors in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 23: 335-47. PMID 21116052 DOI: 10.3233/JAD-2010-101242  0.76
2011 Darreh-Shori T, Forsberg A, Modiri N, Andreasen N, Blennow K, Kamil C, Ahmed H, Almkvist O, LÃ¥ngström B, Nordberg A. Differential levels of apolipoprotein E and butyrylcholinesterase show strong association with pathological signs of Alzheimer's disease in the brain in vivo. Neurobiology of Aging. 32: 2320.e15-32. PMID 20538374 DOI: 10.1016/j.neurobiolaging.2010.04.028  0.76
2011 Schöll M, Almkvist O, Axelman K, Stefanova E, Wall A, Westman E, LÃ¥ngström B, Lannfelt L, Graff C, Nordberg A. Glucose metabolism and PIB binding in carriers of a His163Tyr presenilin 1 mutation. Neurobiology of Aging. 32: 1388-99. PMID 19796846 DOI: 10.1016/j.neurobiolaging.2009.08.016  0.76
2011 Darreh-Shori T, Modiri N, Blennow K, Baza S, Kamil C, Ahmed H, Andreasen N, Nordberg A. The apolipoprotein E ε4 allele plays pathological roles in AD through high protein expression and interaction with butyrylcholinesterase. Neurobiology of Aging. 32: 1236-48. PMID 19713000 DOI: 10.1016/j.neurobiolaging.2009.07.015  0.76
2011 Nordberg A. Interview: Imaging in Alzheimer's disease Imaging in Medicine. 3: 389-392. DOI: 10.2217/iim.11.34  0.76
2010 Wicklund L, Leão RN, Strömberg AM, Mousavi M, Hovatta O, Nordberg A, Marutle A. Î’-amyloid 1-42 oligomers impair function of human embryonic stem cell-derived forebrain cholinergic neurons. Plos One. 5: e15600. PMID 21179413 DOI: 10.1371/journal.pone.0015600  0.76
2010 Kadir A, Nordberg A. Target-specific PET probes for neurodegenerative disorders related to dementia. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 1418-30. PMID 20810758 DOI: 10.2967/jnumed.110.077164  0.76
2010 Hedberg MM, Clos MV, Ratia M, Gonzalez D, Lithner CU, Camps P, Muñoz-Torrero D, Badia A, Giménez-Llort L, Nordberg A. Effect of huprine X on β-amyloid, synaptophysin and α7 neuronal nicotinic acetylcholine receptors in the brain of 3xTg-AD and APPswe transgenic mice. Neuro-Degenerative Diseases. 7: 379-88. PMID 20689242 DOI: 10.1159/000287954  0.76
2010 Degerman Gunnarsson M, Lindau M, Wall A, Blennow K, Darreh-Shori T, Basu S, Nordberg A, Larsson A, Lannfelt L, Basun H, Kilander L. Pittsburgh compound-B and Alzheimer's disease biomarkers in CSF, plasma and urine: An exploratory study. Dementia and Geriatric Cognitive Disorders. 29: 204-12. PMID 20332638 DOI: 10.1159/000281832  0.76
2010 Forsberg A, Almkvist O, Engler H, Wall A, LÃ¥ngström B, Nordberg A. High PIB retention in Alzheimer's disease is an early event with complex relationship with CSF biomarkers and functional parameters. Current Alzheimer Research. 7: 56-66. PMID 20205671 DOI: 10.2174/156720510790274446  0.76
2010 Nordberg A. Amyloid imaging in early detection of Alzheimer's disease. Neuro-Degenerative Diseases. 7: 136-8. PMID 20197692 DOI: 10.1159/000289223  0.76
2010 Nordberg A, Rinne JO, Kadir A, LÃ¥ngström B. The use of PET in Alzheimer disease. Nature Reviews. Neurology. 6: 78-87. PMID 20139997 DOI: 10.1038/nrneurol.2009.217  0.76
2010 Nilbratt M, Porras O, Marutle A, Hovatta O, Nordberg A. Neurotrophic factors promote cholinergic differentiation in human embryonic stem cell-derived neurons. Journal of Cellular and Molecular Medicine. 14: 1476-84. PMID 19799651 DOI: 10.1111/j.1582-4934.2009.00916.x  0.76
2010 Nordberg A. Imaging and behavior in Parkinson’s disease: Functional imaging Neuropsychiatric and Cognitive Changes in Parkinson's Disease and Related Movement Disorders: Diagnosis and Management. 89-96. DOI: 10.1017/CBO9781139856669.009  0.76
2009 LÃ¥ngström B, Grahnen A, Honoré PH, Borlak J, Bergstrom M, Nielsen B, Vanderheyden J, Watanabe Y, Josephsson R, Høilund-Carlsen PF, Schwaiger M, Larson SM, Goldenberg DM, Melzer A, Engler H, ... ... Nordberg A, et al. The risk of exaggerated risk aversion-a life and death struggle for molecular imaging. European Journal of Nuclear Medicine and Molecular Imaging. 36: 1693-4. PMID 19618184 DOI: 10.1007/s00259-009-1190-1  0.76
2009 Ferris S, Nordberg A, Soininen H, Darreh-Shori T, Lane R. Progression from mild cognitive impairment to Alzheimer's disease: effects of sex, butyrylcholinesterase genotype, and rivastigmine treatment. Pharmacogenetics and Genomics. 19: 635-46. PMID 19617863 DOI: 10.1097/FPC.0b013e32832f8c17  0.76
2009 Peskind E, Nordberg A, Darreh-Shori T, Soininen H. Safety of lumbar puncture procedures in patients with Alzheimer's disease. Current Alzheimer Research. 6: 290-2. PMID 19519311 DOI: 10.2174/156720509788486509  0.76
2009 Nordberg A. Molecular imaging markers in clinical trials in Alzheimer s disease. The Journal of Nutrition, Health & Aging. 13: 346-7. PMID 19300875 DOI: 10.1007/s12603-009-0038-5  0.76
2009 Nordberg A, Darreh-Shori T, Peskind E, Soininen H, Mousavi M, Eagle G, Lane R. Different cholinesterase inhibitor effects on CSF cholinesterases in Alzheimer patients. Current Alzheimer Research. 6: 4-14. PMID 19199870 DOI: 10.2174/156720509787313961  0.76
2009 Nordberg A. The future: new methods of imaging exploration in Alzheimer's disease. Frontiers of Neurology and Neuroscience. 24: 47-53. PMID 19182462 DOI: 10.1159/000197883  0.76
2009 Svedberg MM, Hall H, Hellström-Lindahl E, Estrada S, Guan Z, Nordberg A, LÃ¥ngström B. [(11)C]PIB-amyloid binding and levels of Abeta40 and Abeta42 in postmortem brain tissue from Alzheimer patients. Neurochemistry International. 54: 347-57. PMID 19162107 DOI: 10.1016/j.neuint.2008.12.016  0.76
2009 Kelicen P, CincioÄŸlu M, Hizli F, Nordberg A. Abeta(25-35) attenuated SREBP level in nuclear extracts of serum-deprived human neuroblastoma cells. Neurochemical Research. 34: 845-50. PMID 18751890 DOI: 10.1007/s11064-008-9832-4  0.76
2008 Blomquist G, Engler H, Nordberg A, Ringheim A, Wall A, Forsberg A, Estrada S, Frändberg P, Antoni G, Långström B. Unidirectional Influx and Net Accumulation of PIB. The Open Neuroimaging Journal. 2: 114-25. PMID 19526073 DOI: 10.2174/1874440000802010114  0.76
2008 Nordberg A. Amyloid imaging in Alzheimer's disease. Neuropsychologia. 46: 1636-41. PMID 18468648 DOI: 10.1016/j.neuropsychologia.2008.03.020  0.76
2008 Lane R, Feldman HH, Meyer J, He Y, Ferris SH, Nordberg A, Darreh-Shori T, Soininen H, Pirttilä T, Farlow MR, Sfikas N, Ballard C, Greig NH. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease. Pharmacogenetics and Genomics. 18: 289-98. PMID 18334913 DOI: 10.1097/FPC.0b013e3282f63f29  0.76
2008 Kadir A, Andreasen N, Almkvist O, Wall A, Forsberg A, Engler H, Hagman G, Lärksäter M, Winblad B, Zetterberg H, Blennow K, LÃ¥ngström B, Nordberg A. Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer's disease. Annals of Neurology. 63: 621-31. PMID 18300284 DOI: 10.1002/ana.21345  0.76
2008 Nordberg A. Amyloid plaque imaging in vivo: current achievement and future prospects. European Journal of Nuclear Medicine and Molecular Imaging. 35: S46-50. PMID 18188557 DOI: 10.1007/s00259-007-0700-2  0.76
2008 Hedberg MM, Svedberg MM, Mustafiz T, Yu WF, Mousavi M, Guan ZZ, Unger C, Nordberg A. Transgenic mice overexpressing human acetylcholinesterase and the Swedish amyloid precursor protein mutation: effect of nicotine treatment. Neuroscience. 152: 223-33. PMID 18164554 DOI: 10.1016/j.neuroscience.2007.11.022  0.76
2008 Johansson A, Savitcheva I, Forsberg A, Engler H, LÃ¥ngström B, Nordberg A, Askmark H. [(11)C]-PIB imaging in patients with Parkinson's disease: preliminary results. Parkinsonism & Related Disorders. 14: 345-7. PMID 17855149 DOI: 10.1016/j.parkreldis.2007.07.010  0.76
2008 Engler H, Santillo AF, Wang SX, Lindau M, Savitcheva I, Nordberg A, Lannfelt L, LÃ¥ngström B, Kilander L. In vivo amyloid imaging with PET in frontotemporal dementia. European Journal of Nuclear Medicine and Molecular Imaging. 35: 100-6. PMID 17846768 DOI: 10.1007/s00259-007-0523-1  0.76
2008 Forsberg A, Engler H, Almkvist O, Blomquist G, Hagman G, Wall A, Ringheim A, LÃ¥ngström B, Nordberg A. PET imaging of amyloid deposition in patients with mild cognitive impairment. Neurobiology of Aging. 29: 1456-65. PMID 17499392 DOI: 10.1016/j.neurobiolaging.2007.03.029  0.76
2008 Kadir A, Darreh-Shori T, Almkvist O, Wall A, Grut M, Strandberg B, Ringheim A, B Eriksson, Blomquist G, LÃ¥ngström B, Nordberg A. PET imaging of the in vivo brain acetylcholinesterase activity and nicotine binding in galantamine-treated patients with AD. Neurobiology of Aging. 29: 1204-17. PMID 17379359 DOI: 10.1016/j.neurobiolaging.2007.02.020  0.76
2008 Darreh-Shori T, Kadir A, Almkvist O, Grut M, Wall A, Blomquist G, Eriksson B, LÃ¥ngström B, Nordberg A. Inhibition of acetylcholinesterase in CSF versus brain assessed by 11C-PMP PET in AD patients treated with galantamine. Neurobiology of Aging. 29: 168-84. PMID 17196712 DOI: 10.1016/j.neurobiolaging.2006.09.020  0.76
2008 Hellström-Lindahl E, Ravid R, Nordberg A. Age-dependent decline of neprilysin in Alzheimer's disease and normal brain: inverse correlation with A beta levels. Neurobiology of Aging. 29: 210-21. PMID 17098332 DOI: 10.1016/j.neurobiolaging.2006.10.010  0.76
2007 Marutle A, Ohmitsu M, Nilbratt M, Greig NH, Nordberg A, Sugaya K. Modulation of human neural stem cell differentiation in Alzheimer (APP23) transgenic mice by phenserine. Proceedings of the National Academy of Sciences of the United States of America. 104: 12506-11. PMID 17640880 DOI: 10.1073/pnas.0705346104  0.76
2007 Nordberg A. Amyloid imaging in Alzheimer's disease. Current Opinion in Neurology. 20: 398-402. PMID 17620873 DOI: 10.1097/WCO.0b013e3281a47744  0.76
2007 Famer D, Meaney S, Mousavi M, Nordberg A, Björkhem I, Crisby M. Regulation of alpha- and beta-secretase activity by oxysterols: cerebrosterol stimulates processing of APP via the alpha-secretase pathway. Biochemical and Biophysical Research Communications. 359: 46-50. PMID 17532301 DOI: 10.1016/j.bbrc.2007.05.033  0.76
2007 Qi XL, Nordberg A, Xiu J, Guan ZZ. The consequences of reducing expression of the alpha7 nicotinic receptor by RNA interference and of stimulating its activity with an alpha7 agonist in SH-SY5Y cells indicate that this receptor plays a neuroprotective role in connection with the pathogenesis of Alzheimer's disease. Neurochemistry International. 51: 377-83. PMID 17493709 DOI: 10.1016/j.neuint.2007.04.002  0.76
2007 Yu WF, Guan ZZ, Nordberg A. Postnatal upregulation of alpha4 and alpha3 nicotinic receptor subunits in the brain of alpha7 nicotinic receptor-deficient mice. Neuroscience. 146: 1618-28. PMID 17434683 DOI: 10.1016/j.neuroscience.2007.03.002  0.76
2007 Nilsson LN, Lannfelt L, Basun H, Nordberg A, Winblad B. [Don't underestimate the value of transgenic animal models of Alzheimer disease]. LäKartidningen. 104: 798-9; discussion 79. PMID 17432800  0.76
2007 Roensch J, Crisby M, Nordberg A, Xiao Y, Zhang LJ, Guan ZZ. Effects of statins on alpha7 nicotinic receptor, cholinesterase and alpha-form of secreted amyloid precursor peptide in SH-SY5Y cells. Neurochemistry International. 50: 800-6. PMID 17412455 DOI: 10.1016/j.neuint.2007.02.001  0.76
2007 Celsi F, Svedberg M, Unger C, Cotman CW, Carrì MT, Ottersen OP, Nordberg A, Torp R. Beta-amyloid causes downregulation of calcineurin in neurons through induction of oxidative stress. Neurobiology of Disease. 26: 342-52. PMID 17344052 DOI: 10.1016/j.nbd.2006.12.022  0.76
2007 Kadir A, Darreh-Shori T, Almkvist O, Wall A, LÃ¥ngström B, Nordberg A. Changes in brain 11C-nicotine binding sites in patients with mild Alzheimer's disease following rivastigmine treatment as assessed by PET. Psychopharmacology. 191: 1005-14. PMID 17310387 DOI: 10.1007/s00213-007-0725-z  0.76
2007 Nilbratt M, Friberg L, Mousavi M, Marutle A, Nordberg A. Retinoic acid and nerve growth factor induce differential regulation of nicotinic acetylcholine receptor subunit expression in SN56 cells. Journal of Neuroscience Research. 85: 504-14. PMID 17203487 DOI: 10.1002/jnr.21156  0.76
2007 Nat R, Nilbratt M, Narkilahti S, Winblad B, Hovatta O, Nordberg A. Neurogenic neuroepithelial and radial glial cells generated from six human embryonic stem cell lines in serum-free suspension and adherent cultures. Glia. 55: 385-99. PMID 17152062 DOI: 10.1002/glia.20463  0.76
2007 Apostolova LG, Dutton RA, Dinov ID, Hayashi KM, Toga AW, Cummings JL, Thompson PM, Engler H, Forsberg A, Almkvist O, Blomquist G, Larsson E, Savitcheva I, Wall A, Ringheim A, ... ... Nordberg A, et al. Disease mechanisms in neuroscience Neuroscientist. 13: 99. DOI: 10.1177/10738584070130020301  0.76
2007 Forsberg A, Engler H, Blomquist G, Almkvist O, Hagman G, Wall A, Ringheim A, Langstrom B, Nordberg A. PET imaging of amyloid depositions in MCI patients using PIB Journal of Cerebral Blood Flow and Metabolism. 27: BO03-01.  0.76
2006 Darreh-Shori T, Brimijoin S, Kadir A, Almkvist O, Nordberg A. Differential CSF butyrylcholinesterase levels in Alzheimer's disease patients with the ApoE epsilon4 allele, in relation to cognitive function and cerebral glucose metabolism. Neurobiology of Disease. 24: 326-33. PMID 16973370 DOI: 10.1016/j.nbd.2006.07.013  0.76
2006 Darreh-Shori T, Meurling L, Pettersson T, Hugosson K, Hellström-Lindahl E, Andreasen N, Minthon L, Nordberg A. Changes in the activity and protein levels of CSF acetylcholinesterases in relation to cognitive function of patients with mild Alzheimer's disease following chronic donepezil treatment. Journal of Neural Transmission (Vienna, Austria : 1996). 113: 1791-801. PMID 16868793 DOI: 10.1007/s00702-006-0526-2  0.76
2006 Engler H, Forsberg A, Almkvist O, Blomquist G, Larsson E, Savitcheva I, Wall A, Ringheim A, LÃ¥ngström B, Nordberg A. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease. Brain : a Journal of Neurology. 129: 2856-66. PMID 16854944 DOI: 10.1093/brain/awl178  0.76
2006 Kadir A, Almkvist O, Wall A, LÃ¥ngström B, Nordberg A. PET imaging of cortical 11C-nicotine binding correlates with the cognitive function of attention in Alzheimer's disease. Psychopharmacology. 188: 509-20. PMID 16832659 DOI: 10.1007/s00213-006-0447-7  0.76
2006 Rautemaa R, Nordberg A, Wuolijoki-Saaristo K, Meurman JH. Bacterial aerosols in dental practice - a potential hospital infection problem? The Journal of Hospital Infection. 64: 76-81. PMID 16820249 DOI: 10.1016/j.jhin.2006.04.011  0.76
2006 Nordberg A. Mechanisms behind the neuroprotective actions of cholinesterase inhibitors in Alzheimer disease. Alzheimer Disease and Associated Disorders. 20: S12-8. PMID 16772751 DOI: 10.1097/01.wad.0000213804.59187.2d  0.76
2006 Kelicen P, Nordberg A. Feedback regulation of SREBP and aromatase in A beta(25-35)-supplemented human neuroblastoma cells. Cellular and Molecular Neurobiology. 26: 225-35. PMID 16767510 DOI: 10.1007/s10571-006-9060-x  0.76
2006 Xiu J, Nordberg A, Qi X, Guan ZZ. Influence of cholesterol and lovastatin on alpha-form of secreted amyloid precursor protein and expression of alpha7 nicotinic receptor on astrocytes. Neurochemistry International. 49: 459-65. PMID 16675062 DOI: 10.1016/j.neuint.2006.03.007  0.76
2006 Mousavi M, Nordberg A. Expression of the alpha7, alpha4 and alpha3 nicotinic receptor subtype in the brain and adrenal medulla of transgenic mice carrying genes coding for human AChE and beta-amyloid. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 24: 269-73. PMID 16574369 DOI: 10.1016/j.ijdevneu.2006.02.002  0.76
2006 Nordberg A, Eriksdotter-Jönhagen M, Garlind A, Grut M, Freund-Levi Y, Cornelius C, Ekström A, Fastbom J, Sedvall M, Viitanen M. [Administration of symptom-relieving drugs in Alzheimer disease is beneficial]. LäKartidningen. 103: 369-71. PMID 16536040  0.76
2006 Unger C, Svedberg MM, Yu WF, Hedberg MM, Nordberg A. Effect of subchronic treatment of memantine, galantamine, and nicotine in the brain of Tg2576 (APPswe) transgenic mice. The Journal of Pharmacology and Experimental Therapeutics. 317: 30-6. PMID 16354790 DOI: 10.1124/jpet.105.098566  0.76
2006 Stefanova E, Wall A, Almkvist O, Nilsson A, Forsberg A, LÃ¥ngström B, Nordberg A. Longitudinal PET evaluation of cerebral glucose metabolism in rivastigmine treated patients with mild Alzheimer's disease. Journal of Neural Transmission (Vienna, Austria : 1996). 113: 205-18. PMID 16049637 DOI: 10.1007/s00702-005-0312-6  0.76
2006 Nordberg A. Emerging biology of the cholinergic system across the spectrum of Alzheimer's disease International Psychogeriatrics. 18: S3-S16. DOI: 10.1017/S1041610206003991  0.76
2005 Xiu J, Nordberg A, Shan KR, Yu WF, Olsson JM, Nordman T, Mousavi M, Guan ZZ. Lovastatin stimulates up-regulation of alpha7 nicotinic receptors in cultured neurons without cholesterol dependency, a mechanism involving production of the alpha-form of secreted amyloid precursor protein. Journal of Neuroscience Research. 82: 531-41. PMID 16240392 DOI: 10.1002/jnr.20658  0.76
2005 Unger C, Hedberg MM, Mustafiz T, Svedberg MM, Nordberg A. Early changes in Abeta levels in the brain of APPswe transgenic mice--implication on synaptic density, alpha7 neuronal nicotinic acetylcholine- and N-methyl-D-aspartate receptor levels. Molecular and Cellular Neurosciences. 30: 218-27. PMID 16107318 DOI: 10.1016/j.mcn.2005.07.012  0.76
2005 Xiu J, Nordberg A, Zhang JT, Guan ZZ. Expression of nicotinic receptors on primary cultures of rat astrocytes and up-regulation of the alpha7, alpha4 and beta2 subunits in response to nanomolar concentrations of the beta-amyloid peptide(1-42). Neurochemistry International. 47: 281-90. PMID 15955596 DOI: 10.1016/j.neuint.2005.04.023  0.76
2005 Falk L, Nordberg A, Seiger A, Kjaeldgaard A, Hellström-Lindahl E. Smoking during early pregnancy affects the expression pattern of both nicotinic and muscarinic acetylcholine receptors in human first trimester brainstem and cerebellum. Neuroscience. 132: 389-97. PMID 15802191 DOI: 10.1016/j.neuroscience.2004.12.049  0.76
2005 Yu WF, Guan ZZ, Bogdanovic N, Nordberg A. High selective expression of alpha7 nicotinic receptors on astrocytes in the brains of patients with sporadic Alzheimer's disease and patients carrying Swedish APP 670/671 mutation: a possible association with neuritic plaques. Experimental Neurology. 192: 215-25. PMID 15698636 DOI: 10.1016/j.expneurol.2004.12.015  0.76
2005 Francis PT, Nordberg A, Arnold SE. A preclinical view of cholinesterase inhibitors in neuroprotection: do they provide more than symptomatic benefits in Alzheimer's disease? Trends in Pharmacological Sciences. 26: 104-11. PMID 15681028 DOI: 10.1016/j.tips.2004.12.010  0.76
2005 Unger C, Svedberg MM, Schutte M, Bednar I, Nordberg A. Effect of memantine on the alpha 7 neuronal nicotinic receptors, synaptophysin- and low molecular weight MAP-2 levels in the brain of transgenic mice over-expressing human acetylcholinesterase. Journal of Neural Transmission (Vienna, Austria : 1996). 112: 255-68. PMID 15372325 DOI: 10.1007/s00702-004-0183-2  0.76
2004 Mousavi M, Bednar I, Nordberg A. Selective changes in expression of different nicotinic receptor subtypes in brain and adrenal glands of mice carrying human mutated gene for APP or over-expressing human acetylcholinestrase. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 22: 545-9. PMID 15465284 DOI: 10.1016/j.ijdevneu.2004.07.005  0.76
2004 Svedberg MM, Bednar I, Nordberg A. Effect of subchronic galantamine treatment on neuronal nicotinic and muscarinic receptor subtypes in transgenic mice overexpressing human acetylcholinesterase. Neuropharmacology. 47: 558-71. PMID 15380373 DOI: 10.1016/j.neuropharm.2004.06.009  0.76
2004 Nordberg A. Is amyloid plaque imaging the key to monitoring brain pathology of Alzheimer's disease in vivo? European Journal of Nuclear Medicine and Molecular Imaging. 31: 1540-3. PMID 15372212 DOI: 10.1007/s00259-004-1677-8  0.76
2004 Bednar I, Friberg L, Nordberg A. Modulation of dopamine release by the nicotinic agonist epibatidine in the frontal cortex and the nucleus accumbens of naive and chronic nicotine treated rats. Neurochemistry International. 45: 1049-55. PMID 15337304 DOI: 10.1016/j.neuint.2004.05.004  0.76
2004 Nordberg A. PET imaging of amyloid in Alzheimer's disease. The Lancet. Neurology. 3: 519-27. PMID 15324720 DOI: 10.1016/S1474-4422(04)00853-1  0.76
2004 Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Bäckman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, DeCarli C, et al. Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. Journal of Internal Medicine. 256: 240-6. PMID 15324367 DOI: 10.1111/j.1365-2796.2004.01380.x  0.76
2004 Shan KR, Qi XL, Long YG, Nordberg A, Guan ZZ. Decreased nicotinic receptors in PC12 cells and rat brains influenced by fluoride toxicity--a mechanism relating to a damage at the level in post-transcription of the receptor genes. Toxicology. 200: 169-77. PMID 15212813 DOI: 10.1016/j.tox.2004.03.013  0.76
2004 Hellström-Lindahl E, Court J, Keverne J, Svedberg M, Lee M, Marutle A, Thomas A, Perry E, Bednar I, Nordberg A. Nicotine reduces A beta in the brain and cerebral vessels of APPsw mice. The European Journal of Neuroscience. 19: 2703-10. PMID 15147304 DOI: 10.1111/j.0953-816X.2004.03377.x  0.76
2004 Almkvist O, Darreh-Shori T, Stefanova E, Spiegel R, Nordberg A. Preserved cognitive function after 12 months of treatment with rivastigmine in mild Alzheimer's disease in comparison with untreated AD and MCI patients. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 11: 253-61. PMID 15061827 DOI: 10.1046/j.1468-1331.2003.00757.x  0.76
2004 Darreh-Shori T, Hellström-Lindahl E, Flores-Flores C, Guan ZZ, Soreq H, Nordberg A. Long-lasting acetylcholinesterase splice variations in anticholinesterase-treated Alzheimer's disease patients. Journal of Neurochemistry. 88: 1102-13. PMID 15009666 DOI: 10.1046/j.1471-4159.2003.02230.x  0.76
2004 Hellström-Lindahl E, Mousavi M, Ravid R, Nordberg A. Reduced levels of Abeta 40 and Abeta 42 in brains of smoking controls and Alzheimer's patients. Neurobiology of Disease. 15: 351-60. PMID 15006705 DOI: 10.1016/j.nbd.2003.11.024  0.76
2004 Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergström M, Savitcheva I, Huang GF, Estrada S, Ausén B, Debnath ML, Barletta J, Price JC, Sandell J, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Annals of Neurology. 55: 306-19. PMID 14991808 DOI: 10.1002/ana.20009  0.76
2004 Nordberg A. Functional studies of cholinergic activity in normal and Alzheimer disease states by imaging technique. Progress in Brain Research. 145: 301-10. PMID 14650924 DOI: 10.1016/S0079-6123(03)45021-8  0.76
2003 Klunk WE, Engler H, Nordberg A, Bacskai BJ, Wang Y, Price JC, Bergström M, Hyman BT, LÃ¥ngström B, Mathis CA. Imaging the pathology of Alzheimer's disease: amyloid-imaging with positron emission tomography. Neuroimaging Clinics of North America. 13: 781-9, ix. PMID 15024961 DOI: 10.1016/S1052-5149(03)00092-3  0.76
2003 Nordberg A. Toward an early diagnosis and treatment of Alzheimer's disease. International Psychogeriatrics / Ipa. 15: 223-37. PMID 14756159 DOI: 10.1017/S1041610203009499  0.76
2003 Mousavi M, Hellström-Lindahl E, Guan ZZ, Shan KR, Ravid R, Nordberg A. Protein and mRNA levels of nicotinic receptors in brain of tobacco using controls and patients with Alzheimer's disease. Neuroscience. 122: 515-20. PMID 14614915 DOI: 10.1016/S0306-4522(03)00460-3  0.76
2003 Falk L, Nordberg A, Seiger A, Kjaeldgaard A, Hellström-Lindahl E. Higher expression of alpha7 nicotinic acetylcholine receptors in human fetal compared to adult brain. Brain Research. Developmental Brain Research. 142: 151-60. PMID 12711366 DOI: 10.1016/S0165-3806(03)00063-4  0.76
2003 Guan ZZ, Yu WF, Nordberg A. Dual effects of nicotine on oxidative stress and neuroprotection in PC12 cells. Neurochemistry International. 43: 243-9. PMID 12689604 DOI: 10.1016/S0197-0186(03)00009-3  0.76
2003 Svedberg MM, Svensson AL, Bednar I, Nordberg A. Neuronal nicotinic and muscarinic receptor subtypes at different ages of transgenic mice overexpressing human acetylcholinesterase. Neuroscience Letters. 340: 148-52. PMID 12668258 DOI: 10.1016/S0304-3940(03)00092-2  0.76
2003 Wolf H, Jelic V, Gertz HJ, Nordberg A, Julin P, Wahlund LO. A critical discussion of the role of neuroimaging in mild cognitive impairment. Acta Neurologica Scandinavica. Supplementum. 179: 52-76. PMID 12603252  0.76
2003 Stefanova E, Blennow K, Almkvist O, Hellström-Lindahl E, Nordberg A. Cerebral glucose metabolism, cerebrospinal fluid-beta-amyloid1-42 (CSF-Abeta42), tau and apolipoprotein E genotype in long-term rivastigmine and tacrine treated Alzheimer disease (AD) patients. Neuroscience Letters. 338: 159-63. PMID 12566177 DOI: 10.1016/S0304-3940(02)01384-8  0.76
2003 Yu WF, Nordberg A, Ravid R, Guan ZZ. Correlation of oxidative stress and the loss of the nicotinic receptor alpha 4 subunit in the temporal cortex of patients with Alzheimer's disease. Neuroscience Letters. 338: 13-6. PMID 12565129 DOI: 10.1016/S0304-3940(02)01361-7  0.76
2003 Guan ZZ, Yu WF, Shan KR, Nordman T, Olsson J, Nordberg A. Loss of nicotinic receptors induced by beta-amyloid peptides in PC12 cells: possible mechanism involving lipid peroxidation. Journal of Neuroscience Research. 71: 397-406. PMID 12526028 DOI: 10.1002/jnr.10496  0.76
2003 Chen J, Shan KR, Long YG, Wang YN, Nordberg A, Guan ZZ. Selective decreases of nicotinic acetylcholine receptors in PC12 cells exposed to fluoride. Toxicology. 183: 235-42. PMID 12504354 DOI: 10.1016/S0300-483X(02)00551-6  0.76
2002 Jelic V, König T, Dierks T, Nordberg A, Wahlund LO. Electroencephalography and glucose metabolism (positron-emission tomography) in dementing disorders. Methods and Findings in Experimental and Clinical Pharmacology. 24: 21. PMID 12809079  0.76
2002 Long YG, Wang YN, Chen J, Jiang SF, Nordberg A, Guan ZZ. Chronic fluoride toxicity decreases the number of nicotinic acetylcholine receptors in rat brain. Neurotoxicology and Teratology. 24: 751-7. PMID 12460657 DOI: 10.1016/S0892-0362(02)00273-8  0.76
2002 Guan ZZ, Nordberg A, Mousavi M, Rinne JO, Hellström-Lindahl E. Selective changes in the levels of nicotinic acetylcholine receptor protein and of corresponding mRNA species in the brains of patients with Parkinson's disease. Brain Research. 956: 358-66. PMID 12445706 DOI: 10.1016/S0006-8993(02)03571-0  0.76
2002 Darreh-Shori T, Almkvist O, Guan ZZ, Garlind A, Strandberg B, Svensson AL, Soreq H, Hellström-Lindahl E, Nordberg A. Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months. Neurology. 59: 563-72. PMID 12196650  0.76
2002 Hellström-Lindahl E, Nordberg A. Smoking during pregnancy: a way to transfer the addiction to the next generation? Respiration; International Review of Thoracic Diseases. 69: 289-93. PMID 12169737 DOI: 10.1159/000063261  0.76
2002 Marutle A, Unger C, Hellström-Lindahl E, Wang J, Puoliväli J, Tanila H, Nordberg A, Zhang X. Elevated levels of Abeta1-40 and Abeta1-42 do not alter the binding sites of nicotinic receptor subtypes in the brain of APPswe and PS1 double transgenic mice. Neuroscience Letters. 328: 269-72. PMID 12147323  0.52
2002 Bednar I, Paterson D, Marutle A, Pham TM, Svedberg M, Hellström-Lindahl E, Mousavi M, Court J, Morris C, Perry E, Mohammed A, Zhang X, Nordberg A. Selective nicotinic receptor consequences in APP(SWE) transgenic mice. Molecular and Cellular Neurosciences. 20: 354-65. PMID 12093166  0.52
2002 Svedberg MM, Svensson AL, Johnson M, Lee M, Cohen O, Court J, Soreq H, Perry E, Nordberg A. Upregulation of neuronal nicotinic receptor subunits alpha4, beta2, and alpha7 in transgenic mice overexpressing human acetylcholinesterase. Journal of Molecular Neuroscience : Mn. 18: 211-22. PMID 12059039 DOI: 10.1385/JMN:18:3:211  0.76
2002 Abbas N, Bednar I, Mix E, Marie S, Paterson D, Ljungberg A, Morris C, Winblad B, Nordberg A, Zhu J. Up-regulation of the inflammatory cytokines IFN-gamma and IL-12 and down-regulation of IL-4 in cerebral cortex regions of APP(SWE) transgenic mice. Journal of Neuroimmunology. 126: 50-7. PMID 12020956  0.44
2002 Hartvig P, Nordberg A, Torstenson R, Sjöberg P, Fasth KJ, LÃ¥ngström B. Interaction of a muscarinic cholinergic agonist on acetylcholine and dopamine receptors in the monkey brain studied with positron emission tomography. Dementia and Geriatric Cognitive Disorders. 13: 199-204. PMID 12006729 DOI: 10.1159/000057697  0.76
2001 Marutle A, Zhang X, Court J, Piggott M, Johnson M, Perry R, Perry E, Nordberg A. Laminar distribution of nicotinic receptor subtypes in cortical regions in schizophrenia. Journal of Chemical Neuroanatomy. 22: 115-26. PMID 11470559  0.52
2001 Narahashi T, Söderpalm B, Ericson M, Olausson P, Engel JA, Zhang X, Nordberg A, Marszalec W, Aistrup GL, Schmidt LG, Kalouti U, Smolka And M, Hedlund L. Mechanisms of alcohol-nicotine interactions: alcoholics versus smokers. Alcoholism, Clinical and Experimental Research. 25: 152S-156S. PMID 11391065  0.76
2001 Arnáiz E, Jelic V, Almkvist O, Wahlund LO, Winblad B, Valind S, Nordberg A. Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment. Neuroreport. 12: 851-5. PMID 11277595  0.76
2001 Almkvist O, Jelic V, Amberla K, Hellström-Lindahl E, Meurling L, Nordberg A. Responder characteristics to a single oral dose of cholinesterase inhibitor: a double-blind placebo-controlled study with tacrine in Alzheimer patients. Dementia and Geriatric Cognitive Disorders. 12: 22-32. PMID 11125238  0.76
2000 Algotsson A, Nordberg A, Winblad B. Apolipoprotein E varepsilon4 allele has an impact on vascular reactivity in Alzheimer's disease. Archives of Gerontology and Geriatrics. 31: 221-231. PMID 11154777  0.44
2000 Dierks T, Jelic V, Pascual-Marqui RD, Wahlund L, Julin P, Linden DE, Maurer K, Winblad B, Nordberg A. Spatial pattern of cerebral glucose metabolism (PET) correlates with localization of intracerebral EEG-generators in Alzheimer's disease. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 111: 1817-24. PMID 11018498  0.44
2000 Sihver W, Nordberg A, Långström B, Mukhin AG, Koren AO, Kimes AS, London ED. Development of ligands for in vivo imaging of cerebral nicotinic receptors. Behavioural Brain Research. 113: 143-57. PMID 10942041 DOI: 10.1016/S0166-4328(00)00209-6  0.76
2000 Zhang X, Paterson D, James R, Gong ZH, Liu C, Rosecrans J, Nordberg A. Rats exhibiting acute behavioural tolerance to nicotine have more [125I]alpha-bungarotoxin binding sites in brain than rats not exhibiting tolerance. Behavioural Brain Research. 113: 105-15. PMID 10942037 DOI: 10.1016/S0166-4328(00)00205-9  0.76
2000 Jelic V, Johansson SE, Almkvist O, Shigeta M, Julin P, Nordberg A, Winblad B, Wahlund LO. Quantitative electroencephalography in mild cognitive impairment: longitudinal changes and possible prediction of Alzheimer's disease. Neurobiology of Aging. 21: 533-40. PMID 10924766  0.76
1999 Sihver W, Gillberg PG, Svensson AL, Nordberg A. Autoradiographic comparison of [3H](-)nicotine, [3H]cytisine and [3H]epibatidine binding in relation to vesicular acetylcholine transport sites in the temporal cortex in Alzheimer's disease. Neuroscience. 94: 685-96. PMID 10579560  0.48
1999 Wahlund LO, Basun H, Almkvist O, Julin P, Axelman K, Shigeta M, Jelic V, Nordberg A, Lannfelt L. A follow-up study of the family with the Swedish APP 670/671 Alzheimer's disease mutation. Dementia and Geriatric Cognitive Disorders. 10: 526-33. PMID 10559570 DOI: 10.1159/000017200  0.76
1999 Herholz K, Nordberg A, Salmon E, Perani D, Kessler J, Mielke R, Halber M, Jelic V, Almkvist O, Collette F, Alberoni M, Kennedy A, Hasselbalch S, Fazio F, Heiss WD. Impairment of neocortical metabolism predicts progression in Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 10: 494-504. PMID 10559566  0.76
1999 Guan ZZ, Zhang X, Blennow K, Nordberg A. Decreased protein level of nicotinic receptor alpha7 subunit in the frontal cortex from schizophrenic brain. Neuroreport. 10: 1779-82. PMID 10501574  0.36
1999 Sihver W, Fasth KJ, Horti AG, Koren AO, Bergström M, Lu L, Hagberg G, Lundqvist H, Dannals RF, London ED, Nordberg A, Långström B. Synthesis and characterization of binding of 5-[76Br]bromo-3-[[2(S)-azetidinyl]methoxy]pyridine, a novel nicotinic acetylcholine receptor ligand, in rat brain. Journal of Neurochemistry. 73: 1264-72. PMID 10461920 DOI: 10.1046/j.1471-4159.1999.0731264.x  0.76
1999 Bäckman L, Andersson JL, Nyberg L, Winblad B, Nordberg A, Almkvist O. Brain regions associated with episodic retrieval in normal aging and Alzheimer's disease. Neurology. 52: 1861-70. PMID 10371535  0.76
1999 Marutle A, Warpman U, Bogdanovic N, Lannfelt L, Nordberg A. Neuronal nicotinic receptor deficits in Alzheimer patients with the Swedish amyloid precursor protein 670/671 mutation. Journal of Neurochemistry. 72: 1161-9. PMID 10037489  0.52
1998 Jelic V, Dierks T, Amberla K, Almkvist O, Winblad B, Nordberg A. Longitudinal changes in quantitative EEG during long-term tacrine treatment of patients with Alzheimer's disease. Neuroscience Letters. 254: 85-8. PMID 9779926 DOI: 10.1016/S0304-3940(98)00669-7  0.76
1998 Nordberg A, Amberla K, Shigeta M, Lundqvist H, Viitanen M, Hellström-Lindahl E, Johansson M, Andersson J, Hartvig P, Lilja A, LÃ¥ngström B, Winblad B. Long-term tacrine treatment in three mild Alzheimer patients: effects on nicotinic receptors, cerebral blood flow, glucose metabolism, EEG, and cognitive abilities. Alzheimer Disease and Associated Disorders. 12: 228-37. PMID 9772028  0.48
1998 Marutle A, Warpman U, Bogdanovic N, Nordberg A. Regional distribution of subtypes of nicotinic receptors in human brain and effect of aging studied by (+/-)-[3H]epibatidine. Brain Research. 801: 143-9. PMID 9729344  0.52
1998 Eriksdotter Jönhagen M, Nordberg A, Amberla K, Bäckman L, Ebendal T, Meyerson B, Olson L, Seiger, Shigeta M, Theodorsson E, Viitanen M, Winblad B, Wahlund LO. Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 9: 246-57. PMID 9701676 DOI: 10.1159/000017069  0.76
1998 Sihver W, Gillberg PG, Nordberg A. Laminar distribution of nicotinic receptor subtypes in human cerebral cortex as determined by [3H](-)nicotine, [3H]cytisine and [3H]epibatidine in vitro autoradiography. Neuroscience. 85: 1121-33. PMID 9681951  0.48
1997 Bäckman L, Almkvist O, Andersson J, Nordberg A, Winblad B, Reineck R, Långström B. Brain activation in young and older adults during implicit and explicit retrieval. Journal of Cognitive Neuroscience. 9: 378-91. PMID 23965013 DOI: 10.1162/jocn.1997.9.3.378  0.76
1997 Wimo A, Karlsson G, Nordberg A, Winblad B. Treatment of Alzheimer disease with tacrine: a cost-analysis model. Alzheimer Disease and Associated Disorders. 11: 191-200. PMID 9437436  0.44
1997 Hartvig P, Torstenson R, Bjurling P, Fasth KJ, Längström B, Nordberg A. Regional brain distribution and binding of the muscarinic receptor agonist CI-979 studied by positron emission tomography in the monkey. Dementia and Geriatric Cognitive Disorders. 8: 259-66. PMID 9298626  0.76
1997 Svensson AL, Warpman U, Hellström-Lindahl E, Bogdanovic N, Lannfelt L, Nordberg A. Nicotinic receptors, muscarinic receptors and choline acetyltransferase activity in the temporal cortex of Alzheimer patients with differing apolipoprotein E genotypes. Neuroscience Letters. 232: 37-40. PMID 9292886  0.48
1997 Jelic V, Julin P, Shigeta M, Nordberg A, Lannfelt L, Winblad B, Wahlund LO. Apolipoprotein E epsilon4 allele decreases functional connectivity in Alzheimer's disease as measured by EEG coherence. Journal of Neurology, Neurosurgery, and Psychiatry. 63: 59-65. PMID 9221969  0.44
1997 Corder EH, Jelic V, Basun H, Lannfelt L, Valind S, Winblad B, Nordberg A. No difference in cerebral glucose metabolism in patients with Alzheimer disease and differing apolipoprotein E genotypes. Archives of Neurology. 54: 273-7. PMID 9074396  0.44
1996 Algotsson A, Nordberg A, Lannfelt L, Almkvist O, Winblad B. Apolipoprotein E epsilon4 allele, skin vessel reactivity and vascular risk factors in Alzheimer's disease. Archives of Gerontology and Geriatrics. 22: 223-32. PMID 15374172  0.76
1996 Andreasen N, Eriksson S, Karlsson I, Lindahl B, Lund M, Nordberg A, Wimo A, Winblad B, Astrand R. [More accurate diagnosis could identify patients suitable for tacrine therapy]. LäKartidningen. 93: 1200. PMID 8656831  0.44
1996 Lunell E, Bergström M, Antoni G, LÃ¥ngström B, Nordberg A. Nicotine deposition and body distribution from a nicotine inhaler and a cigarette studied with positron emission tomography. Clinical Pharmacology and Therapeutics. 59: 593-4. PMID 8646831 DOI: 10.1016/S0009-9236(96)90188-5  0.32
1995 Algotsson A, Nordberg A, Almkvist O, Winblad B. Skin vessel reactivity is impaired in Alzheimer's disease. Neurobiology of Aging. 16: 577-82. PMID 8544908  0.76
1995 Algotsson A, Nordberg A, Winblad B. Influence of age and gender on skin vessel reactivity to endothelium-dependent and endothelium-independent vasodilators tested with iontophoresis and a laser Doppler perfusion imager. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 50: M121-7. PMID 7874588  0.44
1995 Bergström M, Nordberg A, Lunell E, Antoni G, LÃ¥ngström B. Regional deposition of inhaled 11C-nicotine vapor in the human airway as visualized by positron emission tomography. Clinical Pharmacology and Therapeutics. 57: 309-17. PMID 7697948 DOI: 10.1016/0009-9236(95)90156-6  0.32
1994 Olson L, Bäckman L, Ebendal T, Eriksdotter-Jönhagen M, Hoffer B, Humpel C, Freedman R, Giacobini M, Meyerson B, Nordberg A. Role of growth factors in degeneration and regeneration in the central nervous system; clinical experiences with NGF in Parkinson's and Alzheimer's diseases. Journal of Neurology. 242: S12-5. PMID 7699401 DOI: 10.1007/BF00939233  0.76
1993 Nordberg A, Viitanen M, Winblad B. [New studies on Alzheimer's disease. Promising therapeutic results with tacrine]. LäKartidningen. 90: 1561-3. PMID 8483354  0.48
1993 Hellström-Lindahl E, Winblad B, Nordberg A. Muscarinic and nicotinic receptor changes in the cortex and thalamus of brains of chronic alcoholics. Brain Research. 620: 42-8. PMID 8402197  0.44
1993 Grafström M, Nordberg A, Winblad B. Abuse is in the eye of the beholder. Report by family members about abuse of demented persons in home care. A total population-based study. Scandinavian Journal of Social Medicine. 21: 247-55. PMID 8310277  0.44
1993 Shigeta M, Persson A, Viitanen M, Winblad B, Nordberg A. EEG regional changes during long-term treatment with tetrahydroaminoacridine (THA) in Alzheimer's disease. Acta Neurologica Scandinavica. Supplementum. 149: 58-61. PMID 8128842  0.48
1993 Amberla K, Nordberg A, Viitanen M, Winblad B. Long-term treatment with tacrine (THA) in Alzheimer's disease--evaluation of neuropsychological data. Acta Neurologica Scandinavica. Supplementum. 149: 55-7. PMID 8128841  0.48
1993 Tham A, Nordberg A, Grissom FE, Carlsson-Skwirut C, Viitanen M, Sara VR. Insulin-like growth factors and insulin-like growth factor binding proteins in cerebrospinal fluid and serum of patients with dementia of the Alzheimer type. Journal of Neural Transmission. Parkinson's Disease and Dementia Section. 5: 165-76. PMID 7690227  0.48
1992 Nordberg A, Alafuzoff I, Winblad B. Nicotinic and muscarinic subtypes in the human brain: changes with aging and dementia. Journal of Neuroscience Research. 31: 103-11. PMID 1613816 DOI: 10.1002/jnr.490310115  0.44
1992 Nordberg A, Lilja A, Lundqvist H, Hartvig P, Amberla K, Viitanen M, Warpman U, Johansson M, Hellström-Lindahl E, Bjurling P. Tacrine restores cholinergic nicotinic receptors and glucose metabolism in Alzheimer patients as visualized by positron emission tomography. Neurobiology of Aging. 13: 747-58. PMID 1491741  0.48
1991 Copeland JR, Adem A, Jacob P, Nordberg A. A comparison of the binding of nicotine and nornicotine stereoisomers to nicotinic binding sites in rat brain cortex. Naunyn-Schmiedeberg's Archives of Pharmacology. 343: 123-7. PMID 2067586 DOI: 10.1007/BF00168598  0.76
1991 Nordberg A, Hartvig P, Lilja A, Viitanen M, Amberla K, Lundqvist H, Andersson J, Nybäck H, Ulin J, Anderson Y. Nicotine receptors in the brain of patients with Alzheimer's disease. Studies with 11C-nicotine and positron emission tomography. Acta Radiologica. Supplementum. 376: 165-6. PMID 1666767  0.76
1990 Herrera-Marschitz M, Goiny M, Utsumi H, Ferre S, HÃ¥kansson L, Nordberg A, Ungerstedt U. Effect of unilateral nucleus basalis lesion on cortical and striatal acetylcholine and dopamine release monitored in vivo with microdialysis. Neuroscience Letters. 110: 172-9. PMID 2325883 DOI: 10.1016/0304-3940(90)90807-L  0.76
1990 Nilsson-HÃ¥kansson L, Lai Z, Nordberg A. Tetrahydroaminoacridine induces opposite changes in muscarinic and nicotinic receptors in rat brain. European Journal of Pharmacology. 186: 301-5. PMID 2289530 DOI: 10.1016/0014-2999(90)90448-F  0.76
1990 Nordberg A, Appel SH, Gottfries CG, Mesulam MM. Future prospects of research on central cholinergic mechanisms. Progress in Brain Research. 84: 415-8. PMID 2267313  0.76
1990 Nordberg A, Adem A, Nilsson-HÃ¥kansson L, Bucht G, Hartvig P, Alafuzoff I, Viitanen M, LÃ¥ngström B, Winblad B. New approaches to clinical and postmortem investigations of cholinergic mechanisms. Progress in Brain Research. 84: 313-20. PMID 2267305  0.48
1990 Nordberg A, Hartvig P, Lilja A, Viitanen M, Amberla K, Lundqvist H, Andersson Y, Ulin J, Winblad B, LÃ¥ngström B. Decreased uptake and binding of 11C-nicotine in brain of Alzheimer patients as visualized by positron emission tomography. Journal of Neural Transmission. Parkinson's Disease and Dementia Section. 2: 215-24. PMID 2257061  0.48
1990 Sakurada T, Alufuzoff I, Winblad B, Nordberg A. Substance P-like immunoreactivity, choline acetyltransferase activity and cholinergic muscarinic receptors in Alzheimer's disease and multi-infarct dementia. Brain Research. 521: 329-32. PMID 1698512  0.44
1989 Nordberg A, Hartvig P, Lundqvist H, Antoni G, Ulin J, LÃ¥ngström B. Uptake and regional distribution of (+)-(R)- and (-)-(S)-N-[methyl-11C]-nicotine in the brains of rhesus monkey. An attempt to study nicotinic receptors in vivo. Journal of Neural Transmission. Parkinson's Disease and Dementia Section. 1: 195-205. PMID 2789067  0.32
1989 Adem A, Nordberg A, Jossan SS, Sara V, Gillberg PG. Quantitative autoradiography of nicotinic receptors in large cryosections of human brain hemispheres. Neuroscience Letters. 101: 247-52. PMID 2771170 DOI: 10.1016/0304-3940(89)90540-5  0.76
1989 Nordberg A, Nilsson-HÃ¥kansson L, Adem A, Hardy J, Alafuzoff I, Lai Z, Herrera-Marschitz M, Winblad B. The role of nicotinic receptors in the pathophysiology of Alzheimer's disease. Progress in Brain Research. 79: 353-62. PMID 2685906  0.76
1989 Nybäck H, Nordberg A, LÃ¥ngström B, Halldin C, Hartvig P, Ahlin A, Swahn CG, Sedvall G. Attempts to visualize nicotinic receptors in the brain of monkey and man by positron emission tomography. Progress in Brain Research. 79: 313-9. PMID 2587749  0.76
1989 Adem A, Jossan SS, d'Argy R, Gillberg PG, Nordberg A, Winblad B, Sara V. Insulin-like growth factor 1 (IGF-1) receptors in the human brain: quantitative autoradiographic localization. Brain Research. 503: 299-303. PMID 2557967  0.48
1989 Nordberg A, Nilsson-HÃ¥kansson L, Adem A, Lai Z, Winblad B. Multiple actions of THA on cholinergic neurotransmission in Alzheimer brains. Progress in Clinical and Biological Research. 317: 1169-78. PMID 2557636  0.76
Show low-probability matches.